Results 211 to 220 of about 11,127 (277)

Asthma heterogeneity and severity [PDF]

, 2016

core   +1 more source

Mepolizumab: Which condition benefits more: Nasal polyps or eosinophilic asthma? [PDF]

Tuberk Toraks
Açar E, Köylüce S, Şeker S, Bozkurt Yilmaz HE, Aktaş Yapici E, Arslan B, Paçaci Çetin G, Türk M, Yilmaz İ.   +8 more
europepmc   +1 more source

Clinical remission in chronic rhinosinusitis with nasal polyps with biologics: a premature promise? [PDF]

Eur Respir Rev
Gelardi M, Giancaspro R.
europepmc   +1 more source

Achieving remission in severe asthma. [PDF]

Chin Med J Pulm Crit Care Med
Thawanaphong S, Nolasco S, Nair P.
europepmc   +1 more source

Early Intervention with Mepolizumab, Corticosteroids, and Intravenous Immunoglobulin for Dupilumab-Triggered Eosinophilic Granulomatosis with Polyangiitis: A Case Report. [PDF]

J Asthma Allergy
Kaburaki S, Tanaka T, Kamio K, Tanaka Y, Kasahara K, Seike M.   +5 more
europepmc   +1 more source

Current and Emerging Therapies for Eosinophilic Esophagitis (EoE): A Comprehensive Review. [PDF]

Pharmaceutics
Musburger BG, Gonzalez Echeandia M, Suskind EL, Suskind DL, Zheng HB, Mark D.   +5 more
europepmc   +1 more source

Biologic Therapies for Severe Asthma: Current Insights and Future Directions. [PDF]

J Clin Med
Faria N, Costa MI, Fernandes AL, Fernandes A, Fernandes B, Machado DC, Machado F, Simão L, Ribeiro L, Ferreira L, Boaventura R, Lima R, Ferreira J.   +12 more
europepmc   +1 more source

How does asthma coexistence affect the strategic selection of biologic therapies in CRSwNP management? [PDF]

Front Allergy
Ozdemir I, Bayar Muluk N, Yazır M, Cingi C.   +3 more
europepmc   +1 more source

Inflammation in Asthma: Mechanistic Insights and the Role of Biologics in Therapeutic Frontiers. [PDF]

Biomedicines
Reza MI, Ambhore NS.
europepmc   +1 more source